A bedtime dose of ARB was better than a morning dose in improving baroreflex sensitivity and urinary albumin excretion - The J-TOP study

Clinical and Experimental Hypertension

Volumn 34, Issue 7, 2012, Pages 488-492

  Eguchi, Kazuo ^a   Shimizu, Motohiro ^a   Hoshide, Satoshi ^a   Shimada, Kazuyuki ^a   Kario, Kazuomi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin receptor blocker; Baroreflex sensitivity; Bedtime dose; Urinary albumin

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; CREATININE;

ADULT; ANGINA PECTORIS; ANTIHYPERTENSIVE THERAPY; ARTICLE; BEDTIME DOSAGE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETES MELLITUS; DOSAGE SCHEDULE COMPARISON; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MICROALBUMINURIA; MORNING DOSAGE; PRESSORECEPTOR REFLEX; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; SMOKING; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN; URINALYSIS; URINARY EXCRETION;

AGED; ALBUMINURIA; ANGIOTENSIN RECEPTOR ANTAGONISTS; BAROREFLEX; BLOOD PRESSURE; CREATININE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84870443787     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2012.666604     Document Type: Article

References (20)

1. Portaluppi F, Lemmer B. Chronobiology and chronotherapy of ischemic heart disease. Adv Drug Deliv Rev 2007; 59:952-965.
2. Hermida RC, Ayala DE, Fernández JR, Calvo C. Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension 2008; 51:69-76.
3. Hermida RC, Ayala DE, Mojón A, Alonso I, Fernández Jr. Reduction of morning blood pressure surge after treatment with nifedipine GITS at bedtime, but not upon awakening, in essential hypertension. Blood Press Monit 2009; 14:152-159.
4. Kario K, Hoshide S, Shimizu M, et al. Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) study. J Hypertens 2010; 28:1574-1583.
5. Huang C, Yoshimoto M, Miki K, Johns EJ. The contribution of brain angiotensin II to the baroreflex regulation of renal sympathetic nerve activity in conscious normotensive and hypertensive rats. J Physiol 2006; 574:597-604.
6. Ogihara T, Kikuchi K, Matsuoka H, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009; 32:3-107.
7. Eguchi K, Tomizawa H, Ishikawa J, et al. Factors associated with baroreflex sensitivity: association with morning blood pressure. Hypertens Res 2007; 30:723-728.
8. Eguchi K, Tomizawa H, Ishikawa J, et al. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure. J Cardiovasc Pharmacol 2007; 49:394-400.
9. Palmero HA, Caeiro TF, Iosa DJ, Bas J. Baroreceptor reflex sensitivity index derived from Phase 4 of the Valsalvamaneuver. Hypertension 1981; 3:II-134-II-137.
10. Bonyhay I, Jokkel G, Kollai M. Relation between baroreflex sensitivity and carotid artery elasticity in healthy humans. Am J Physiol 1996; 271:H1139-H1144.
11. Lantelme P, Khettab F, Custaud MA, et al. Spontaneous baroreflex sensitivity: toward an ideal index of cardiovascular risk in hypertension? J Hypertens 2002; 20: 935-944.
12. Parati G, Di Rienzo M, Mancia G. How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens 2000; 18:7-19.
13. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005; 46:200-204.
14. Johns EJ. Angiotensin II in the brain and the autonomic control of the kidney. Exp Physiol 2005; 90:163-168.
15. Chern CM, Hsu HY, Hu HH, Chen YY, Hsu LC, Chao AC. Effects of atenolol and losartan on baroreflex sensitivity and heart rate variability in uncomplicated essential hypertension. J Cardiovasc Pharmacol 2006; 47:169-174.
16. Hikosaka M, Yuasa F, Yuyama R, et al. Candesartan and arterial baroreflex sensitivity and sympathetic nerve activity in patients with mild heart failure. J Cardiovasc Pharmacol 2002; 40:875-880.
17. Fridman KU, Wysocki M, Friberg PR, Andersson OK. Candesartan cilexetil in hypertension: effects of six weeks' treatment on haemodynamics, baroreceptor sensitivity and the renin-angiotensin-aldosterone system. Blood Press 1999; 8:242-247.
18. Vaile JC, Chowdhary S, Osman F, et al. Effects of angiotensin II (AT1) receptor blockade on cardiac vagal control in heart failure. Clin Sci 2001; 101:559-566.
19. Svensson P, de Faire U, Sleight P, Yusuf S, Comparative OJ. Effects of ramipril on ambulatory and office blood pressures: a HOPE substudy. Hypertension 2001; 38:e28-e32.
20. Dolan E, Stanton AV, Thom S, et al. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients - an Anglo-Scandinavian cardiac outcomes trial substudy. J Hypertens 2009; 27:876-885.